专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20130090482A1 CRYSTALLINE FORMS OF 4, 4'- [4-FLUORO-7-( ETHYNYL)-2-METHYL-1H-INDOLE-1,3-DIYL] DIBUTANOIC ACID, 4,4'-[2-METHYL-7-( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID, AND 4,4'-[4-FLUORO-2-METHYL-7- ( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID 有权
标题翻译： 4' - [4-氟-7-（乙基）-2-甲基-1H-吲哚-1,3-二基]二苯胺酸的4,4'- [2-甲基-7-（乙基））-1H-吲哚-1,3-二氧化物]二琥珀酸和4,4' - [4-氟-2-甲基-7-（乙基）-1H-吲哚-1,3-二基]二苯胺
公开(公告)号：US20130090482A1
公开(公告)日：2013-04-11
申请号：US13805689
申请日：2011-06-20
申请人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
发明人： Jun Takeuchi , Satoshi Itadani , Junya Ueda , Shizuka Ono , Takahiro Nekado , Manabu Fujita
IPC分类号： C07D209/24
CPC分类号： C07D209/24 , A61K31/405
摘要： The present invention provides type C crystal of compound I, type B crystal of compound II, or type C crystal of compound III set forth in this specification.
摘要翻译：本发明提供了本说明书中列出的化合物I的C型晶体，化合物II的B型晶体或化合物III的C型晶体。

22. 发明授权

US08148023B2 Regulating an oxidizer in an electrochemical cell pumping system 失效
标题翻译：调节电化学电池泵送系统中的氧化剂
公开(公告)号：US08148023B2
公开(公告)日：2012-04-03
申请号：US12270351
申请日：2008-11-13
申请人： Jeffrey W. Schrieber , Jun Takeuchi
发明人： Jeffrey W. Schrieber , Jun Takeuchi
IPC分类号： H01M8/04
CPC分类号： H01M8/04738 , C01B3/0005 , C01B3/34 , C01B2203/0205 , C01B2203/043 , C01B2203/066 , C01B2203/1241 , C01B2203/1247 , C01B2203/1604 , H01M8/04089 , H01M8/04589 , H01M8/04776 , H01M8/0491 , Y02E60/324
摘要： A technique includes operating an electrochemical cell as a pump, including providing a current to the cell and providing a fuel flow to an anode chamber of the cell. The technique includes communicating an anode exhaust flow from the anode chamber to an oxidizer and controlling the current to regulate a temperature of the oxidizer.
摘要翻译：一种技术包括将电化学电池作为泵操作，包括向电池提供电流并向电池的阳极室提供燃料流。该技术包括将阳极废气流从阳极室传递到氧化剂并控制电流以调节氧化剂的温度。

23. 发明申请

US20110118987A1 PREDICTIVE BLOOD SUGAR LEVEL CALCULATING DEVICE, PREDICTIVE BLOOD SUGAR LEVEL CALCULATING METHOD, AND PROGRAM THEREOF 审中-公开
标题翻译：预测血液糖水平计算装置，预测血糖计算方法及其程序
公开(公告)号：US20110118987A1
公开(公告)日：2011-05-19
申请号：US12946961
申请日：2010-11-16
申请人： Jun Takeuchi , Junko Hasegawa , Megumi Sano , Daichi Shimatsu
发明人： Jun Takeuchi , Junko Hasegawa , Megumi Sano , Daichi Shimatsu
IPC分类号： G06F19/00
CPC分类号： G06F19/3456 , G06F19/3475 , G06F19/3481 , G16H50/50
摘要： A predictive blood sugar level calculating device acquires meal information about meal intake, calorie consumption information about calorie consumption, pulse information, and the like, calculates predictive blood sugar level change curves indicating change in blood sugar levels based on the plurality of information in a time series using predetermined numerical formulas, and combines the predictive blood sugar level change curves, thereby reducing an error between the calculated predictive blood sugar level curve and an actual change in a blood sugar level occurring in a human body.
摘要翻译：预测血糖值计算装置获取关于膳食摄入的膳食信息，关于卡路里消耗的卡路里消耗信息，脉搏信息等，基于一段时间内的多个信息计算表示血糖水平变化的预测血糖水平变化曲线使用预定数值公式，并结合预测血糖水平变化曲线，从而减少计算出的预测血糖水平曲线与人体内出现的血糖水平的实际变化之间的误差。

24. 发明授权

US07763610B2 Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases 失效
标题翻译：羧酸衍生的苯并恶嗪作为治疗呼吸系统疾病的药剂
公开(公告)号：US07763610B2
公开(公告)日：2010-07-27
申请号：US10569482
申请日：2004-08-31
申请人： Jun Takeuchi , Satoshi Itadani , Yoshisuke Nakayama , Tadashi Tatsumi , Shinya Takahashi , Manabu Fujita
发明人： Jun Takeuchi , Satoshi Itadani , Yoshisuke Nakayama , Tadashi Tatsumi , Shinya Takahashi , Manabu Fujita
IPC分类号： A61K31/538
CPC分类号： C07C205/60 , A61K31/538 , A61K45/06 , C07C205/37 , C07D265/36 , C07D413/04 , A61K2300/00
摘要： The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.
摘要翻译：本发明涉及式（I）化合物（其中所有符号具有与上述相同的含义）。该化合物拮抗cysLT2，因此可用作预防和/或治疗呼吸系统疾病如支气管哮喘，支气管哮喘，慢性阻塞性肺病，肺炎，慢性支气管炎，肺炎（例如间质性肺炎等）的药剂，严重急性呼吸综合征（SARS），急性呼吸窘迫综合征（ARDS），过敏性鼻炎，鼻窦炎（如急性鼻窦炎，慢性鼻窦炎等）等，或作为祛痰药或镇咳药。

25. 发明授权

US07202879B2 Image processing method, image processing apparatus, electronic device, image processing program, and recording medium on which the same program is recorded 有权
标题翻译：图像处理方法，图像处理装置，电子装置，图像处理程序和记录有相同程序的记录介质
公开(公告)号：US07202879B2
公开(公告)日：2007-04-10
申请号：US09966267
申请日：2001-10-01
申请人： Kiyoaki Murai , Hidekuni Moriya , Jun Takeuchi
发明人： Kiyoaki Murai , Hidekuni Moriya , Jun Takeuchi
IPC分类号： G09G5/10
CPC分类号： G09G5/06 , G09G3/2022 , G09G3/2051 , G09G3/2059 , G09G3/3622 , G09G2320/0247 , G09G2320/0266 , G09G2320/0271 , G09G2320/0276 , G09G2320/0285 , G09G2340/02 , Y10S345/904
摘要： The present invention provides an image processing device that does not convert image data into a grayscale value which may cause defects in the displayed images, such as flickering or fluctuation, when performing color reduction/pseudo-halftone processing to convert the data into data which can be displayed on the color LCD panel (20). Alternatively, the frequency of occurrence of such a grayscale value can be reduced. The present invention thereby prevents a decrease in the display quality of an image output apparatus in advance by processing data supplied to the image output apparatus, such as a color LCD panel.
摘要翻译：本发明提供了一种图像处理装置，其不进行将图像数据转换为灰度值，该灰度值可能导致显示图像中的缺陷，例如闪烁或变化，当执行减色/伪半色调处理以将数据转换成可以显示在彩色LCD面板（20）上。或者，可以减少这种灰度值的发生频率。因此，本发明通过处理提供给诸如彩色LCD面板的图像输出装置的数据来预防图像输出装置的显示质量的降低。

26. 发明申请

US20060194797A1 Condensed ring compound and use thereof 失效
标题翻译：缩合环化合物及其用途
公开(公告)号：US20060194797A1
公开(公告)日：2006-08-31
申请号：US10569482
申请日：2004-08-31
申请人： Jun Takeuchi
发明人： Jun Takeuchi
IPC分类号： A61K31/5415 , A61K31/538 , A61K31/502 , A61K31/498 , A61K31/4709
CPC分类号： C07C205/60 , A61K31/538 , A61K45/06 , C07C205/37 , C07D265/36 , C07D413/04 , A61K2300/00
摘要： The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.
摘要翻译：本发明涉及式（I）化合物（其中所有符号具有与上述相同的含义）。该化合物拮抗cysLT 2 N，因此可用作预防和/或治疗呼吸系统疾病如支气管哮喘，支气管哮喘，慢性阻塞性肺病，肺炎，慢性支气管炎，肺炎的药剂（例如间质性肺炎等），严重急性呼吸综合征（SARS），急性呼吸窘迫综合征（ARDS），过敏性鼻炎，鼻窦炎（例如急性鼻窦炎，慢性鼻窦炎等）等，或作为祛痰药或镇咳药。

27. 发明授权

US09023941B2 Urethane resin particles 有权
标题翻译：聚氨酯树脂颗粒
公开(公告)号：US09023941B2
公开(公告)日：2015-05-05
申请号：US13884771
申请日：2011-11-09
申请人： Shinji Watanabe , Yasuhiro Tsudo , Masaki Inaba , Jun Takeuchi , Yuko Matsumoto
发明人： Shinji Watanabe , Yasuhiro Tsudo , Masaki Inaba , Jun Takeuchi , Yuko Matsumoto
IPC分类号： C08G18/83 , C08G18/42 , C08K5/092 , C08K5/103 , C08G18/80 , C08G18/32 , C08L75/06 , B29C41/00 , B29C41/18 , C08G18/66 , C08G18/73 , C08G18/12 , C08G18/28 , C08G18/34 , C08K5/04 , C08L75/12 , B29K75/00
CPC分类号： C08G18/831 , B29C41/003 , B29C41/18 , B29K2075/00 , C08G18/12 , C08G18/2815 , C08G18/2825 , C08G18/3215 , C08G18/345 , C08G18/346 , C08G18/42 , C08G18/4202 , C08G18/4208 , C08G18/6659 , C08G18/73 , C08G18/8064 , C08G2140/00 , C08K5/04 , C08K5/092 , C08K5/103 , C08L75/12 , C08L75/06
摘要： Provided is a slush molding material which exhibits excellent low-temperature meltability and heat resistance and which can yield a molded product having excellent tensile strength and elongation. The present invention is urethane resin particles (D1) comprising a urethane or urethane-urea resin (U1) that has residues (j) bonded thereto covalently, said residues (j) being residues derived from an at least trivalent aromatic polycarboxylic acid by removing hydroxyl groups, or urethane resin particles (D2) comprising a urethane resin composition (S2) which comprises both a urethane or urethane-urea resin (U2) and a compound (E) that has a residue (j) derived from an at least trivalent aromatic polycarboxylic acid by removing hydroxyl groups, said compound (E) being represented by general formula (1), wherein the residues (j) are linked respectively to urethane or urea groups (u) of the resin (U1) or (U2) by hydrogen bonds.
摘要翻译：提供一种具有优异的低温熔融性和耐热性的搪塑成型材料，并且可以得到具有优异的拉伸强度和伸长率的成型体。本发明是包含具有共价键合的残基（j）的氨基甲酸酯或氨基甲酸酯 - 尿素树脂（U1）的聚氨酯树脂颗粒（D1），所述残基（j）是通过除去羟基从至少三价芳族多元羧酸衍生的残基基团或聚氨酯树脂颗粒（D2），其包含氨基甲酸酯或氨基甲酸酯 - 脲树脂（U2）和具有衍生自至少三价芳族化合物的残基（j）的化合物（E）的聚氨酯树脂组合物（S2）通过除去羟基的多元羧酸，所述化合物（E）由通式（1）表示，其中残基（j）分别通过氢气与树脂（U1）或（U2）的氨基甲酸酯基或脲基（u）连接债券。

28. 发明授权

US08685223B2 Method for operating water electrolysis system 有权
标题翻译：操作水电解系统的方法
公开(公告)号：US08685223B2
公开(公告)日：2014-04-01
申请号：US13007675
申请日：2011-01-17
申请人： Daisuke Kurashina , Kenji Taruya , Jun Takeuchi
发明人： Daisuke Kurashina , Kenji Taruya , Jun Takeuchi
IPC分类号： C25B15/08 , C25B1/04
CPC分类号： C25B1/12 , C25B15/02 , Y02E60/366
摘要： A method for operating a water electrolysis system includes determining whether or not a water electrolysis apparatus is shut down. The water electrolysis system includes the water electrolysis apparatus, a water circulation apparatus, and a gas-liquid separation apparatus. The water electrolysis apparatus includes power feeders provided on an anode side and a cathode side of an electrolyte membrane. The water electrolysis apparatus generates oxygen on the anode side and generates hydrogen on the cathode side at a higher pressure than a pressure of the oxygen by electrolysis of water. Pressure on the cathode side is released when it is determined that the water electrolysis apparatus is shut down. The water circulation apparatus is operated until a concentration of hydrogen remaining on the anode side is a specified value or less under a condition in which a release of pressure on the cathode side is completed.
摘要翻译：一种操作水电解系统的方法，包括确定水电解装置是否关闭。水电解系统包括水电解装置，水循环装置和气液分离装置。水电解装置包括设置在电解质膜的阳极侧和阴极侧的供电装置。水电解装置在阳极侧产生氧气，通过电解水，在比氧气压力高的压力下在阴极侧产生氢气。当确定水电解装置关闭时，阴极侧的压力被释放。运行水循环装置直到在阴极侧的压力释放完成的条件下，残留在阳极侧的氢浓度为规定值以下。

29. 发明授权

US08663434B2 Water electrolysis system and method for operating water electrolysis system 有权
标题翻译：水电解系统及水电解系统运行方法
公开(公告)号：US08663434B2
公开(公告)日：2014-03-04
申请号：US13449314
申请日：2012-04-18
申请人： Jun Takeuchi
发明人： Jun Takeuchi
IPC分类号： C25B1/10 , C25B1/12
CPC分类号： C25B15/02 , C25B1/08 , C25B1/10 , C25B15/08 , H01M8/04208 , H01M8/0656 , H01M2250/20 , Y02E60/366 , Y02T90/32
摘要： A water electrolysis system includes a water electrolysis device, a gas-liquid separator, a water-amount detector, a hydrogen storage device, a hydrogen storage device, a decompressing device, and a control device. The control device includes a residual capacity calculator, a hydrogen production amount calculator, and an electrolysis termination determiner. The residual capacity calculator is configured to calculate a residual capacity of the hydrogen storage device. The hydrogen production amount calculator is configured to calculate an amount of hydrogen produced by the water electrolysis device in a drainage period in which the amount of water in the gas-liquid separator increases to an upper limit from a lower limit. The electrolysis termination determiner is configured to terminate the water electrolysis process when the amount of hydrogen calculated by the hydrogen production amount calculator is greater than the residual capacity calculated by the residual capacity calculator.
摘要翻译：水电解系统包括水电解装置，气液分离器，水量检测器，氢存储装置，氢存储装置，减压装置和控制装置。控制装置包括剩余容量计算器，氢产生量计算器和电解终止确定器。剩余容量计算器被配置为计算氢存储装置的剩余容量。氢产生量计算器被配置为在排气期间计算由水电解装置产生的氢气量，其中气液分离器中的水量从下限增加到上限。电解终止确定器被配置为当由氢产生量计算器计算的氢的量大于由剩余容量计算器计算的剩余容量时终止水电解过程。

30. 发明授权

US08569504B2 Imidazopyridine compound 失效
标题翻译：咪唑并吡啶化合物
公开(公告)号：US08569504B2
公开(公告)日：2013-10-29
申请号：US13378550
申请日：2010-06-16
申请人： Jun Takeuchi , Takayuki Inukai , Masaru Sakai
发明人： Jun Takeuchi , Takayuki Inukai , Masaru Sakai
IPC分类号： A61K31/437 , A61K31/5377 , A61K31/496 , C07D487/04 , C07D487/14 , C07D471/04
CPC分类号： C07D471/04 , A61K31/437
摘要： For the prevention and/or treatment of chymase-mediated diseases such as skin diseases, circulatory diseases, digestive system diseases, respiratory diseases, liver diseases, ocular diseases or the like, a drug is provided having as an active ingredient a compound having extremely strong chymase inhibitory activity, high safety, and high metabolic stability. The compound represented by the formula (I): wherein all symbols have the same meanings as in the description, a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof, is useful as a pharmaceutical ingredient having chymase inhibitory activity for preventing and/or treating of chymase-mediated disease, such as skin diseases, circulatory diseases, digestive system diseases, respiratory diseases, liver diseases, ocular diseases or the like.
摘要翻译：为了预防和/或治疗胃促胰岛素介导的疾病如皮肤疾病，循环系统疾病，消化系统疾病，呼吸系统疾病，肝病，眼部疾病等，提供作为活性成分的具有极强的化合物的药物糜酶抑制活性高，安全性高，代谢稳定性高。由式（I）表示的化合物：其中所有符号具有与描述中相同的含义，其盐，其N-氧化物或其溶剂合物或其前药可用作具有糜酶抑制性的药物成分用于预防和/或治疗胃促胰腺炎介导的疾病如皮肤疾病，循环系统疾病，消化系统疾病，呼吸系统疾病，肝脏疾病，眼部疾病等的活性。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式